Skip To Main Content

Baricitinib

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

OLUMIANT® (baricitinib): Formulation

Olumiant (baricitinib) is supplied as debossed, film-coated, immediate-release tablets available in 2 mg (Olumiant Package Insert, 2018).

Olumiant Prescribing Information

See important safety information, including boxed warning, in the attached prescribing information.

Description of Baricitinib Tablet

Each tablet has a recessed area on both sides of the tablet surface.1

Baricitinib 2-mg  tablets are

  • light pink in color

  • oblong in shape, and

  • not scored.1

Baricitinib 2-mg tablets have a “Lilly” designation on one side and a “2” designation on the other side of the tablet surface.1

Baricitinib 1-mg tablets are

  • very light pink in color

  • round in shape, and

  • not scored.1

Baricitinib 1-mg tablets have a “Lilly” designation on one side and a “1” designation on the other side of the tablet surface.1

Description of Baricitinib Packaging

Baricitinib 2-mg tablets are supplied in bottles of 30 (NDC: 0002-4182-30).1

Baricitinib 1-mg tablets are supplied in bottles of 30 (NDC: 0002-4732-30).1

Enclosed Prescribing Information

OLUMIANT® (baricitinib) tablets, for oral use, Lilly

Reference

1. Olumiant [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.

Glossary

NDC = National Drug Code

Date of Last Review: October 07, 2019

Contact Lilly

Call Us

If you have immediate questions regarding COVID-19, or to report an Adverse Event or Product Complaint, please call us.

Daily Live Support: 9am to 7pm ET.
After Hours: Call Back Support Available

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical